Education
About Us
Working with TipRanks
Follow Us
Viva Biotech Holdings (HK:1873)
:1873
1873 Stock Chart & Stats
HK$2.71
-HK$0.01(-1.20%)
At close: 4:00 PM EST
HK$2.71
-HK$0.01(-1.20%)
Day’s Range― - ―
52-Week RangeHK$0.77 - HK$3.27
Previous CloseN/A
Volume129.00K
Average Volume (3M)10.99M
Market Cap
HK$5.47B
Enterprise ValueHK$4.12B
Total Cash (Recent Filing)HK$904.45M
Total Debt (Recent Filing)HK$1.16B
Price to Earnings (P/E)29.7
Beta2.35
Next Earnings
Mar 26, 2026EPS EstimateN/A
Last Dividend Ex-Date
Jun 16, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding2,128,434,300
10 Day Avg. Volume10,702,922
30 Day Avg. Volume10,985,107
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)0.45
Price to Sales (P/S)0.87
P/FCF Ratio9.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.00Price Target Upside10.70% Upside
Rating ConsensusHold
Number of Analyst Covering0
Viva Biotech Holdings News
1873 FAQ
What was Viva Biotech Holdings’s price range in the past 12 months?
Viva Biotech Holdings lowest stock price was HK$0.77 and its highest was HK$3.27 in the past 12 months.
What is Viva Biotech Holdings’s market cap?
Viva Biotech Holdings’s market cap is HK$5.47B.
When is Viva Biotech Holdings’s upcoming earnings report date?
Viva Biotech Holdings’s upcoming earnings report date is Mar 26, 2026 which is in 159 days.
How were Viva Biotech Holdings’s earnings last quarter?
Viva Biotech Holdings released its earnings results on Aug 28, 2025. The company reported HK$0.055 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.055.
Is Viva Biotech Holdings overvalued?
According to Wall Street analysts Viva Biotech Holdings’s price is currently Undervalued.
Does Viva Biotech Holdings pay dividends?
Viva Biotech Holdings pays a Notavailable dividend of HK$0.01 which represents an annual dividend yield of N/A. See more information on Viva Biotech Holdings dividends here
What is Viva Biotech Holdings’s EPS estimate?
Viva Biotech Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Viva Biotech Holdings have?
Viva Biotech Holdings has 2,128,434,300 shares outstanding.
What happened to Viva Biotech Holdings’s price movement after its last earnings report?
Viva Biotech Holdings reported an EPS of HK$0.055 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.51%.
Which hedge fund is a major shareholder of Viva Biotech Holdings?
Currently, no hedge funds are holding shares in HK:1873
Viva Biotech Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
208.33%
12-Months-Change
Fundamentals
Return on Equity
4.45%
Trailing 12-Months
Asset Growth
-2.26%
Trailing 12-Months
Company Description
Viva Biotech Holdings
Viva Biotech Holdings (1873) is a prominent player in the biotechnology sector, specializing in providing contract research organization (CRO) services. The company focuses on structure-based drug discovery (SBDD) services, which are crucial for pharmaceutical and biotech companies in developing new drugs. Viva Biotech is known for its expertise in protein production, structural biology, and drug screening, offering a comprehensive suite of services that support the drug development process from discovery to clinical stages.
Technical Analysis
Shanghai Junshi Biosciences Co., Ltd. Class H
―
Simcere Pharmaceutical Group Limited
―
Lepu Biopharma Co. Ltd. Class H
―
Shanghai Henlius Biotech, Inc. Class H
―
Shandong Boan Biotechnology Company., Limited. Class H
―
Options Prices
Currently, No data available
---